A. Wischnik
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, PARP inhibition in cancer therapy, BRCA gene mutations in cancer, Breast Cancer Treatment Studies, Cancer Treatment and Pharmacology
Most-Cited Works
- → Topotecan Weekly Versus Conventional 5-Day Schedule in Patients With Platinum-Resistant Ovarian Cancer: A Randomized Multicenter Phase II Trial of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group(2010)103 cited
- → The excretion of ketorolac tromethamine into breast milk after multiple oral dosing(1989)79 cited
- → Tumor cell contamination of peripheral blood stem cell transplants and bone marrow in high-risk breast cancer patients(1997)57 cited
- → A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer(2010)46 cited
- → The Impact of Age on Quality of Life in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Comparative Analysis From the Prospective Multicenter Randomized ADEBAR trial(2016)32 cited
- → Oxygenation of Mammary Tumors as Evaluated by Ultrasound-Guided Computerized-PO2-Histography(1994)31 cited
- → Trastuzumab without chemotherapy in the adjuvant treatment of breast cancer: subgroup results from a large observational study(2018)17 cited
- → Pelvimetrie mittels verschiedener kernspintomographischer Techniken vs. digitale Bildverstärkerradiographie: Genauigkeit, Zeitbedarf und Energiebelastung(1994)16 cited
- → Risk-Benefit Assessment of Tocolytic Drugs(1991)15 cited
- → Short term quality of life with epirubicin-fluorouracil-cyclophosphamid (FEC) and sequential epirubicin/cyclophosphamid-docetaxel (EC-DOC) chemotherapy in patients with primary breast cancer – Results from the prospective multi-center randomized ADEBAR trial(2016)13 cited